| Title | Date | PubMed ID |
|---|
| Structural insights into the interaction of blood coagulation co-factor VIIIa with factor IXa: a computational protein-protein docking and molecular dynamics refinement study. | 2014 Sep 26 | 25157807 |
| Soluble phosphatidylserine binds to two sites on human factor IXa in a Ca2+ dependent fashion to specifically regulate structure and activity. | 2014 | 24979705 |
| Replacing the factor VIII C1 domain with a second C2 domain reduces factor VIII stability and affinity for factor IXa. | 2013 Oct 25 | 24030831 |
| Replacement of the Y450 (c234) phenyl ring in the carboxyl-terminal region of coagulation factor IX causes pleiotropic effects on secretion and enzyme activity. | 2013 Oct 1 | 23994528 |
| A3 domain region 1803-1818 contributes to the stability of activated factor VIII and includes a binding site for activated factor IX. | 2013 Sep 6 | 23884417 |
| Residues of the 39-loop restrict the plasma inhibitor specificity of factor IXa. | 2013 May 3 | 23530052 |
| A sequential mechanism for exosite-mediated factor IX activation by factor XIa. | 2012 Nov 2 | 22961984 |
| Potent anticoagulant aptamer directed against factor IXa blocks macromolecular substrate interaction. | 2012 Apr 13 | 22334679 |
| Correlation of factor IXa subsite modulations with effects on substrate discrimination. | 2012 Mar | 22212890 |
| Sustained release of transgenic human factor IX: preparation, characterization, and in vivo efficacy. | 2011 Oct 3 | 21842870 |